Download PDF
Thromb Haemost 1999; 81(03): 465-466
DOI: 10.1055/s-0037-1614498
Letters to the Editor
Schattauer GmbH

Activated Protein C (APC) Resistance in Young Stroke Patients

Sujata Mohanty
1   From the Department of Haematology, New Delhi, India
,
Renu Saxena
1   From the Department of Haematology, New Delhi, India
,
Madhuri Behari
2   Department of Neurosciences, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
Further Information

Publication History

Received21 August 1998

Accepted after resubmission17 November 1998

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Cushman M, Bhushan F, Bovill E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994; 72: 647.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Halbmayer WM, Haushafer A, Schön R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and arnong healthy subjects. Blood Coag Fibrinol 1994; 5: 51-7.
    CrossrefPubMedSearch in Google Scholar
  • 3 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C-prediction of a cofactor to activated protein C. Proc Natl Acad Sei USA 1993; 90: 1004-8.
    CrossrefPubMedSearch in Google Scholar
  • 4 Trossaert M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, Lane DA. Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709.
    PubMedSearch in Google Scholar